Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

OSI initiates phase I OSI-027 in patients with advanced solid tumors or lymphoma

July 16, 2008

Motesanib diphosphate induces partial responses in patients with thyroid cancer

July 16, 2008

New anticancer agents described in recent patent literature

July 16, 2008

FDA accepts Genta's amendment to NDA for Genasense in CLL as complete response

July 15, 2008

FDA approves OncoGenex's SPA for phase III trial of OGX-011 in HRPC

July 15, 2008

Abraxis receives approval to market Abraxane for breast cancer in China

July 15, 2008

European Commission grants orphan designation to Marqibo for ALL

July 15, 2008

Recent patents disclose new compounds for treating cancer

July 15, 2008

Promising preclinical results with STF-62247 in treating renal cell carcinoma

July 14, 2008

Proteolix initiates dosing in phase Ib clinical trial of proteasome inhibitor carfilzomib

July 14, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...